These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 27452666)

  • 21. Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia).
    Mahwish ; Saeed F; Arshad MS; Nisa MU; Nadeem MT; Arshad MU
    Lipids Health Dis; 2017 Nov; 16(1):211. PubMed ID: 29126447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolite profiling and in vitro biological activities of two commercial bitter melon (Momordica charantia Linn.) cultivars.
    Perez JL; Jayaprakasha GK; Patil BS
    Food Chem; 2019 Aug; 288():178-186. PubMed ID: 30902279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does bitter melon contain an activator of AMP-activated kinase?
    McCarty MF
    Med Hypotheses; 2004; 63(2):340-3. PubMed ID: 15236800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Bitter Melon (Momordica charantia) Extract on the Uptake of
    Kilcar AY; Yildiz O; Dogan T; Sulu E; Takan G; Muftuler FZB
    Anticancer Agents Med Chem; 2020; 20(12):1497-1503. PubMed ID: 32329694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effects of
    Richter E; Geetha T; Burnett D; Broderick TL; Babu JR
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of chemotypes in bitter melon by metabolomics: a plant with potential benefit for management of diabetes in traditional Chinese medicine.
    Zhou S; Allard PM; Wolfrum C; Ke C; Tang C; Ye Y; Wolfender JL
    Metabolomics; 2019 Jul; 15(8):104. PubMed ID: 31321563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats.
    Shetty AK; Kumar GS; Sambaiah K; Salimath PV
    Plant Foods Hum Nutr; 2005 Sep; 60(3):109-12. PubMed ID: 16187012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial.
    Soo May L; Sanip Z; Ahmed Shokri A; Abdul Kadir A; Md Lazin MR
    Complement Ther Clin Pract; 2018 Aug; 32():181-186. PubMed ID: 30057048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of Charantin and Expression of Triterpenoid Biosynthesis Genes in Bitter Melon (Momordica charantia).
    Cuong DM; Jeon J; Morgan AMA; Kim C; Kim JK; Lee SY; Park SU
    J Agric Food Chem; 2017 Aug; 65(33):7240-7249. PubMed ID: 28737900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.
    Leung L; Birtwhistle R; Kotecha J; Hannah S; Cuthbertson S
    Br J Nutr; 2009 Dec; 102(12):1703-8. PubMed ID: 19825210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bitter Melon (
    Sur S; Ray RB
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-α serine/threonine-protein kinase signaling.
    Brennan VC; Wang CM; Yang WH
    J Med Food; 2012 Apr; 15(4):325-34. PubMed ID: 22191569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Momordica charantia (Bitter Melon) on Ischemic Diabetic Myocardium.
    Czompa A; Gyongyosi A; Szoke K; Bak I; Csepanyi E; Haines DD; Tosaki A; Lekli I
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28335529
    [No Abstract]   [Full Text] [Related]  

  • 34. Antioxidant properties and quantitative UPLC-MS analysis of phenolic compounds from extracts of fenugreek (Trigonella foenum-graecum) seeds and bitter melon (Momordica charantia) fruit.
    Kenny O; Smyth TJ; Hewage CM; Brunton NP
    Food Chem; 2013 Dec; 141(4):4295-302. PubMed ID: 23993618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiglycation and Antioxidant Properties of Momordica charantia.
    Aljohi A; Matou-Nasri S; Ahmed N
    PLoS One; 2016; 11(8):e0159985. PubMed ID: 27513747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First Report of Pseudoperonospora cubensis Causing Downy Mildew on Momordica balsamina and M. charantia in North Carolina.
    Wallace E; Adams M; Ivors K; Ojiambo PS; Quesada-Ocampo LM
    Plant Dis; 2014 Sep; 98(9):1279. PubMed ID: 30699625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimized aqueous extraction of saponins from bitter melon for production of a saponin-enriched bitter melon powder.
    Tan SP; Vuong QV; Stathopoulos CE; Parks SE; Roach PD
    J Food Sci; 2014 Jul; 79(7):E1372-81. PubMed ID: 25041538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics Reveals that Momordica charantia Attenuates Metabolic Changes in Experimental Obesity.
    Gong ZG; Zhang J; Xu YJ
    Phytother Res; 2017 Feb; 31(2):296-302. PubMed ID: 27878888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
    Limtrakul P; Khantamat O; Pintha K
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):525-30. PubMed ID: 15248030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial activity and agricultural properties of bitter melon (Momordica charantia L.) grown in northern parts of Turkey: a case study for adaptation.
    Yaldız G; Sekeroglu N; Kulak M; Demirkol G
    Nat Prod Res; 2015; 29(6):543-5. PubMed ID: 25141891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.